Request-for-Information-Stag-BPA.pdf

Request for Information (RFI)

1. RFI Number: HT9425-25-RFI-EMZ01

2. RFI Title: Diagnostica Stago STA R Max® Hemostasis Analyzer.

3. Agency: United States Army Medical Research and Development Command

(MRDC)

4. Office: United States Army Institute of Surgical Research (USAISR)

5. Contracting Office: United States Army Medical Research Acquisition Activity (USAMRAA), Fort Detrick, Frederick, MD.

6. Location: Joint Base San Antonio – Fort Sam Houston, Texas

7. Background: The USAISR currently utilizes two Diagnostica Stago STA R Max® hemostasis analyzers to run samples obtained from coagulation studies. This equipment requires specific reagents and disposable supplies. These coagulation reagents are sole sources reagents and since there are no authorized resellers, these must be procured directly from Diagnostica Stago, Inc.

8. Objectives:

The main objective for this action is to enter into a new Blanket Purchase Agreement (BPA) for consumable supplies for use with the Diagnostica Stago STA R Max® Hemostasis Analyzer.

Items list is as follows:

STA® CONTROL LA 1+2 STA®-Neoplastine® CI Plus 10 STart® Cuvettes

Asserachrom® Total TFPI STA®-Thrombin 10 Ball Dispenser Asserachrom® sEPCR STA®-Stachrom® Protein C Finnpipette PEG 25% STA®-Fibrinogen 5 Finn Tips 1.25mL (Finnpipette Only) Staclot® VIIa-rTF STA®-Unicalibrator Finn Tips 2.5mL (Finnpipette Only)

STA®-Liquid Anti-Xa 4 STA® Coag Control N + Abn Plus Immulon 2HB Plate

STA®-Liquid Anti-Xa 8 STA®-System Control N+P Thrombin Calibrator STA®-Staclot® DRVV Screen 5 STA®-Heparin Control PPP Reagent

STA®-Staclot® DRVV Confirm STA®-Hepanorm® H PPP-Reagent LOW

STA®-Staclot® DRVV Screen 2 STA®-Quality HBPM/LMWH PPP-Reagent HIGH

STA®-Stachrom® TAFI STA®-Deficient XII PRP Reagent STA®-Multi Hep Calibrator STA®-Deficient IX FluCa kit

STA®-Owren-Koller STA®-Deficient VIII MP Reagent STA®-CaCl2 0.025 M STA®-Deficient X K-ASSAY FACTOR XIII CONTROL2

STA®-Quality HNF/UFH2 STA®-Microcontainer (500/box) K-ASSAY FACTOR XIII2

STA®-Procoag-PPL STA®-Deficient VII K-ASSAY FACTOR XIII CALIBRATOR2 PLT VASP/P2Y12 STA®-Deficient V TRINCLOT FACTOR XI

Purified VWF STA®-Deficient II STA-R In-house (Parsippany, NJ) Basic Operator Training

STA®-Liatest® D-Di STA®-Staclot® Protein S STA®-Neoplastine® CI Plus 5 STA®-Liatest® Free Protein S 6 STA®-Staclot® Protein C 1 STA®-Thrombin 2

STA®-Liatest® VWF:Ag STA®-Mini Reducer Fibri-Prest® Automate 2 STA®-VWF:Ag Calibrator STA®-Maxi Reducer STA®-Reptilase® STA®-Liatest® Control N+P STA®-Microcups (100/box) STA®-Stachrom® Plasminogen

STA®-Liatest® FM Stachrom® PAI STA®-Stachrom® Antiplasmin STA®-FM Calibrator Stachrom® Heparin Thermal Paper STA®-FM Control Asserachrom® Protein C 5mL Reduction Ring

Liatest® AT III Asserachrom® tPA White stirring magnet (for STA®- Neoplastine®)

Liatest® Protein S Asserachrom® PF4 Teflon syringe tip and O-Ring kit Staclot® LA 20 STA®-Cleaner Solution Hamilton syringe and o-ring

STA®-PTT Automate 5 STA®-Desorb U STA®-Cuvettes (6 rolls of 1000 cuvettes/box)

STA®-Stachrom® AT III 3 Megamix-Plus SSC2

STA®-C.K. Prest® 5 Magnetic Stir Bars (white triangular)

PTT-LA Screen Ball Vial (1850/vial) Staclot® LA Ball Extractor

9. Information Requested in Capability Statement:

• Confirm ability to deliver the above listed products from Diagnostica Stago, Inc.

10. North American Industry Classification System (NAICS) Code: The NAICS code for this potential action is: 339112 Surgical and Medical Instrument Manufacturing

11. Response Due Date: Interested parties should submit their RFI response electronically by 10:00 am Eastern on 28 October 2024 e-mail to Mr. Eric Zampelli at eric.m.zampelli.civ@health.mil.

12. Instructions to Responders:

12.1 The Government appreciates responses from all capable and qualified sources.

12.2 The Government welcomes input and will accept questions pertaining to this RFI;

however, the Government reserves the right to answer or not answer all questions pertaining to this RFI. Only one set of questions per vendor will be accepted. Telephone requests will not be entertained.

12.3 The subject header of the e-mail for submission of questions and/or the RFI response shall be: HT9425-25-RFI-EMZ01.

12.4 Interested firms should submit a response (Capability Statement) that demonstrates the Offeror’s capabilities identified in this RFI. The Capability Statement shall not exceed five (5) typed pages; additional sheets for cover page, table of contents, tables, and charts will not be counted toward page limitation.

12.5 Fill in the below table when responding to this Sources Sought / RFI.

Question Answer RFI Number Company Name Company Address Point of Contact Phone Number E-mail Address Tax Identification Number (TIN) Cage Code

DUNS

Company Web Page Company Location(s) Company is / is not a Small Business Company is / is not SAM Registered Other Classifications (e.g. 8(a), HubZone, Woman-Owned, Veteran-Owned, Service- Disabled Veteran-Owned)

If 8(a), date that the company graduates from the program.

13. Disclaimer and Important Notes:

In accordance with Federal Acquisition Regulation (FAR) 15.201, "Exchange with industry before receipt of proposals," and FAR 52.215-3, "Request for information (RFI) mailto:eric.m.zampelli.civ@health.mil or Solicitation for Planning Purposes (SFP)," this RFI is for information and planning purposes only, at this time, and shall not be construed as a solicitation or obligation on the part of the USAMRDC. The purpose of this RFI notice is to gain market knowledge.

This RFI is not expected to be a Request for Proposal or Invitation for Bid, nor does it restrict the Government to an ultimate acquisition approach. The Government is not obliged to award a contract or otherwise pay for the information provided in the responses received.

The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its responses are complete and sufficiently detailed to allow the Government to determine the organization's solution. Responders are advised that the Government is under no obligation to acknowledge receipt of the information received, or to provide feedback to respondents regarding any information submitted.

After a review of the responses received, a pre-solicitation synopsis and solicitation may be published on SAM.gov. At this time, no solicitation exists; therefore, please do not request a copy of the solicitation. NO PHONE CALLS PLEASE. It is the responsibility of any potential vendor to monitor SAM.gov for the release of any solicitation or synopsis.

Responses to this notice will not be considered adequate responses to a solicitation.

14. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in submitted responses. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

Original Point of Contact (POC): Eric Zampelli; eric.m.zampelli.civ@health.mil